PMC10090315_01
PMC10090315_02
PMC10090315_03
Peripheral blood smear showing small red blood cells with an enlarged central pale area.
fped-11-1062505-g001.jpg
PMC10090315_03_fped-11-1062505-g001.jpg
F1
Peripheral blood smear showed morphological small red blood cells with an enlarged central pale area (Figure 1).
PMC10090315_04
PMC10090315_05
Follow-up results of hemoglobin, free thyroxine, thyroid-stimulating hormone, urine red blood cells, and urine protein.
fped-11-1062505-g002.jpg
PMC10090315_07_fped-11-1062505-g002.jpg
F2
Urinary proteins are significantly reduced (Figure 2E).
Pituitary MRI showing a mass in the sellar region with a uniform signal and a maximum height of about 15.8 mm. The pituitary stalk is still in the middle, without thickening. MRI showing that the pituitary decreased to 6.2 mm and returned to normal after treatment.
fped-11-1062505-g003.jpg
PMC10090315_05_fped-11-1062505-g003.jpg
F3
After 5 months of treatment, HGB and FT4 returned to the normal range (see Figures 2A,B); re-examination MRI showed that the pituitary decreased to 6.5 mm and returned to normal (Figure 3).
PMC10090315_06
PMC10090315_07
Follow-up results of hemoglobin, free thyroxine, thyroid-stimulating hormone, urine red blood cells, and urine protein.
fped-11-1062505-g002.jpg
PMC10090315_07_fped-11-1062505-g002.jpg
F2
Urinary proteins are significantly reduced (Figure 2E).